Safety and Efficacy of Hypofractionated Radiotherapy Combined with Tyrosine Kinase Inhibitors in Patients with Lung Metastases after Liver Transplantation for Hepatocellular Carcinoma

被引:0
作者
Zhuang, Y. [1 ]
Chen, Y. [1 ]
Du, S. [2 ]
Hu, Y. [1 ]
Zeng, Z. C. [1 ]
机构
[1] Fudan Univ, Zhongshan Hosp, Dept Radiat Oncol, Shanghai, Peoples R China
[2] Fudan Univ, Zhongshan Hosp, Shanghai, Peoples R China
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2023年 / 117卷 / 02期
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2789
引用
收藏
页码:E360 / E360
页数:1
相关论文
共 50 条
[21]   Efficacy of Tumor Markers After Liver Transplantation In Patients With Hepatocellular Carcinoma [J].
Lee, Tae Yun ;
Choi, Ho Joong ;
Ahn, Joseph ;
Hong, Tae Ho ;
You, Young-Kyoung .
TRANSPLANTATION PROCEEDINGS, 2022, 54 (02) :461-467
[22]   Efficacy and safety of transarterial chemoembolization plus sorafenib in patients with recurrent hepatocellular carcinoma after liver transplantation [J].
Zhang, Xia ;
Cai, Lirong ;
Fang, Jian ;
Chen, Fengsui ;
Pan, Fan ;
Zhang, Kun ;
Huang, Qian ;
Huang, Yuju ;
Li, Dongliang ;
Lv, Lizhi ;
Chen, Man ;
Yan, Ruiying ;
Lai, Yanhua ;
Peng, Yonghai ;
Wu, Zhixian .
FRONTIERS IN ONCOLOGY, 2023, 12
[23]   Safety and Efficacy of Hypofractionated Radiotherapy With Capecitabine in Elderly Patients With Urothelial Carcinoma [J].
Leng, Jim ;
Akthar, Adil S. ;
Szmulewitz, Russell Z. ;
O'Donnell, Peter H. ;
Sweis, Randy F. ;
Pitroda, Sean P. ;
Smith, Norm ;
Steinberg, Gary D. ;
Liauw, Stanley L. .
CLINICAL GENITOURINARY CANCER, 2019, 17 (01) :E12-E18
[24]   Safety and Efficacy of Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitor and Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma: A Single Center Experience [J].
Pan, Xian ;
Wu, Shao-Jie ;
Tang, Yi ;
Zhou, Yan-Feng ;
Luo, Jie-Wei ;
Fang, Zhu-Ting .
JOURNAL OF HEPATOCELLULAR CARCINOMA, 2023, 10 :883-892
[25]   MANAGEMENT OF BRAIN METASTASES IN PATIENTS WITH RENAL CELL CARCINOMA IN THE ERA OF TYROSINE KINASE INHIBITORS AND STEREOTACTIC RADIOTHERAPY [J].
Spain, L. ;
Stewart, J. ;
Campbell, A. ;
Lim, A. ;
Joon, D. L. ;
Weickhardt, A. .
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 :42-42
[26]   Impact of Intrahepatic External Beam Radiotherapy in Advanced Hepatocellular Carcinoma Patients Treated with Tyrosine Kinase Inhibitors [J].
Goh, Myung Ji ;
Park, Hee Chul ;
Yu, Jeong Il ;
Kang, Wonseok ;
Gwak, Geum-Youn ;
Paik, Yong-Han ;
Lee, Joon Hyeok ;
Koh, Kwang Cheol ;
Paik, Seung Woon ;
Sinn, Dong Hyun ;
Choi, Moon Seok .
LIVER CANCER, 2023, 12 (05) :467-478
[27]   Comparative efficacy and safety of transarterial chemoembolization combined with tyrosine kinase inhibitors and immune checkpoint inhibitors versus tyrosine kinase inhibitors and immune checkpoint inhibitors alone in advanced hepatocellular carcinoma: a systematic review and meta-analysis [J].
Tian, Hengyu ;
Wan, Chidan .
WORLD JOURNAL OF SURGICAL ONCOLOGY, 2025, 23 (01)
[28]   Efficacy of tyrosine kinase inhibitors (TKIs) in advanced lung adenosquamous carcinoma [J].
Hu, M. ;
Zhang, B. ;
Wang, S. ;
Shen, Y. ;
Qian, J. ;
Zhao, Y. ;
Han, B-H. .
ANNALS OF ONCOLOGY, 2019, 30
[29]   Efficacy of Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis [J].
Peng, Tzu-Rong ;
Weng, Yi-Fang ;
Wu, Ta-Wei ;
Wu, Chao-Chuan ;
Hsu, Chia-Lu ;
Hsu, Ching-Sheng .
CANCERS, 2025, 17 (13)
[30]   The safety and efficacy of tyrosine kinase inhibitors and programmed cell death protein-1 inhibitors combined with HAIC/TACE in the treatment of recurrent unresectable hepatocellular carcinoma [J].
Deng, Wei ;
Xie, Jin ;
Wang, Tao ;
Luo, Laihui ;
Zhu, Guoqing ;
Xiao, Yongqiang ;
Tao, Jiahao ;
Lin, Liucong ;
Ge, Xian ;
Wen, Wu ;
Wang, Minglong ;
Yu, Bin ;
Liu, Yu ;
Luo, Rongguang ;
Wan, Renhua ;
Hu, Zhigao ;
Shan, Renfeng .
BMC CANCER, 2025, 25 (01)